norethindrone has been researched along with Drug Withdrawal Symptoms in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Flowers, CE; Hyde, BM; Wilborn, WH | 1 |
Hardt, W; Nevinny-Stickel, J; Schmidt-Gollwitzer, K; Schmidt-Gollwitzer, M | 1 |
Diethelm, P; Gray, RH; Parker, RA | 1 |
Christiansen, C; Jensen, J; Riis, BJ; Strøm, V | 1 |
Policar, M | 1 |
Berman, E | 1 |
2 trial(s) available for norethindrone and Drug Withdrawal Symptoms
Article | Year |
---|---|
Vaginal bleeding disturbances associated with the discontinuation of long-acting injectable contraceptives. From the World Health Organization Special Programme for Research, Development, and Research Training in Human Reproduction; Task Force on Long-act
Topics: Amenorrhea; Clinical Trials as Topic; Delayed-Action Preparations; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Norethindrone; Pregnancy; Substance Withdrawal Syndrome; Uterine Hemorrhage | 1981 |
Long-term and withdrawal effects of two different oestrogen-progestogen combinations on lipid and lipoprotein profiles in post-menopausal women.
Topics: Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Double-Blind Method; Drug Combinations; Estradiol; Estrogens, Conjugated (USP); Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Random Allocation; Substance Withdrawal Syndrome; Time Factors | 1989 |
4 other study(ies) available for norethindrone and Drug Withdrawal Symptoms
Article | Year |
---|---|
Mechanisms of uterine bleeding in postmenopausal patients receiving estrogen alone or with a progestin.
Topics: Adult; Drug Therapy, Combination; Endometrium; Estrogens, Conjugated (USP); Female; Histocytochemistry; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Microscopy, Electron; Middle Aged; Norethindrone; Norethindrone Acetate; Substance Withdrawal Syndrome; Uterine Hemorrhage | 1983 |
[Progress in the contraceptive use of the LH-RH agonist buserelin: intermittent medication with gestagen-induced withdrawal bleeding].
Topics: Adult; Buserelin; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Drug Evaluation; Endometrium; Estradiol; Female; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Humans; Menstruation; Norethindrone; Norethindrone Acetate; Ovulation; Patient Acceptance of Health Care; Substance Withdrawal Syndrome; Uterine Hemorrhage | 1982 |
Clinical experience with multiphasic oral contraceptives.
Topics: Adult; Carbohydrate Metabolism; Cardiovascular Diseases; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Lipid Metabolism; Middle Aged; Norethindrone; Progesterone Congeners; Substance Withdrawal Syndrome; Uterine Hemorrhage; Virilism | 1986 |
The once-a-month pill.
Topics: Abdomen, Acute; Biopsy; Breast; Chile; Contraceptives, Oral; Dosage Forms; Drug Combinations; Endometrium; Estranes; Female; Headache; Humans; Menstruation; Menstruation Disturbances; Mexico; Mucus; Nausea; Norethindrone; Pain; Peru; Pregnancy; Socioeconomic Factors; Substance Withdrawal Syndrome; Vomiting | 1970 |